Researchers are studying how genetics and environmental factors may influence lung cancer risk and could help shape the ...

The AACR roadmap spotlights LDCT screening, ctDNA MRD monitoring, and new NSCLC/SCLC therapies like DLL3 tarlatamab to close ...

Small cell lung cancer, or SCLC, is fraught with challenges. Patients are often diagnosed late so outcomes are poor; therapeutic advances have stalled due to lackluster funding and the disease, ...

A new preclinical study has demonstrated that combining HER3-DXd with olaparib significantly improves treatment responses in ...

NEW YORK, June 10, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) is pleased to announce the expansion of its Research Advocates. This select group of volunteers are patients, ...

Bacteria in lung tumors may boost the activation of innate immune cells in the presence of a common vitamin metabolite, ...

Indian American researcher recognized for innovative, high-impact research for the understanding, diagnosis, and treatment of ...

Nicole Echols discusses Lung Cancer Initiative, reducing lung cancer stigma, biomarker testing, early detection and support for patients and caregivers. For Nicole Echols, attending the Lung Cancer ...

On August 4, Vinh Bui and Tram Le came to Fred Hutch Cancer Center to celebrate the realization of a lifelong dream of giving back. They were there, along with their children and Fred Hutch leaders ...

Non-small-cell lung cancer (NSCLC) treatment has changed a lot in recent years. Your doctor may check your lung cancer cells for certain DNA changes. If no DNA changes are found, it is called ...

In August, UVA Cancer Center became the first in Virginia to offer lung cancer patients the new drug tarlatamab, approved in May as immunotherapy to supercharge the body’s immune system to fight small ...

Virginia Cancer Specialists, the largest private oncology practice in Northern Virginia, is pleased to welcome Tina Roy, MD, ...